Independent optometry practices have been scrambling to contact thousands of patients in recent weeks after health funds sent letters to policy holders, with many wrongly interpreting them as notification they could no longer access care from their usual optometrist or use optical rebates.
George & Matilda Eyecare (G&M) has relaunched its practice acquisition program and has closed out 2020 by welcoming two additional practices. Read more
Opening a greenfield practice during a pandemic in Australia’s hardest-hit city has thrown up its challenges, especially when it comes to purchasing big ticket items. But DR JAYSON STONE found a way thanks to the efforts of a major supplier.
CooperVision’s MiSight 1 day contact lens has been ranked in Popular Science’s top 100 innovations of 2020, alongside a fast, ultra-cheap coronavirus test, and joining past winners such as the portable defibrillator and the first spacecraft to visit Pluto.
A global investment firm has acquired the US’s largest contact lens retailer 1-800 Contacts for a reported $AU4.2 billion. Read more
Optometry Australia (OA) has been named the 2020 APAC Professional Association of the Year, with judges commending the body’s COVID-19 response. Read more
The world’s largest childhood myopia education resource developed by Australian optometry couple Dr Kate and Dr Paul Gifford has formed a new alliance with the renowned Centre for Ocular Research & Education (CORE). Read more
Specsavers Audiology has screened its one millionth patient for hearing loss since launching nationally in late 2017, with the service now embedded in more than half of the company’s Australian optical locations. Read more
New health fund data has revealed Australians are using their ancillary benefits at pre-COVID levels, while other statistics have shown the number of optical services jumped a staggering 49% once lockdown measures lapsed across the country. Read more
In the space of 23 years AFT Pharmaceuticals has gone from a home-based business to a multinational company. Its eyecare business is also experiencing remarkable growth, and more therapies are in the pipeline, including one for glaucoma.